Extracellular Vesicles Secreted by Human Adipose-derived Stem Cells (hASCs) Improve Survival Rate of Rats with Acute Liver Failure by Releasing lncRNA H19

EBioMedicine. 2018 Aug:34:231-242. doi: 10.1016/j.ebiom.2018.07.015. Epub 2018 Aug 2.

Abstract

It has previously been reported that human adipose-derived stem cells (hASCs) can promote the regeneration of damaged tissues in rats with liver failure through a 'paracrine effect'. Here we demonstrate a therapeutic effect of hASCs derived Extracellular Vesicles (EVs) on rat models with acute liver failure, as shown by the improvement of the survival rate by >70% compared to controls. Gene sequencing of rat liver revealed an increase in human long-chain non-coding RNA (lncRNA) H19 after hASC-derived EVs transplantation. When the H19 coding sequence was silenced in hASCs and EVs were then collected for treatment of rats with liver failure, we saw a decrease in the survival rate to 40%, compared to treatment with EVs generated from non-silenced hASCs. These data indicate that lncRNA H19 may be a potential therapeutic target for the treatment of liver failure.

Keywords: Adipose-derived stem cells; Extracellular vesicles; Liver failure; LncRNA; Regeneration.

MeSH terms

  • Adipose Tissue / cytology
  • Animals
  • Extracellular Vesicles / transplantation*
  • Humans
  • Liver Failure, Acute / metabolism
  • Liver Failure, Acute / therapy*
  • Male
  • RNA, Long Noncoding / administration & dosage*
  • Rats, Sprague-Dawley
  • Regeneration
  • Stem Cells / metabolism

Substances

  • H19 long non-coding RNA
  • RNA, Long Noncoding